New study aims to predict who will develop multiple myeloma
NCT ID NCT07214324
First seen Nov 01, 2025 · Last updated Jun 11, 2026 · Updated 37 times
Summary
This study looks at 60 people with early blood conditions (MGUS or smoldering myeloma) that can sometimes turn into multiple myeloma, a type of blood cancer. Researchers will use advanced genetic and immune system tests to find clues that predict which patients are at higher risk of progression. The goal is to improve early detection and guide future prevention strategies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA (MM) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Istituto Ortopedico Rizzoli IRCCS
ACTIVE_NOT_RECRUITINGBologna, Italy
-
S.C Ematologia - Azienda USL IRCCS di Reggio Emilia
RECRUITINGReggio Emilia, Italy
Contact Email: •••••@•••••
Contact Email: •••••@•••••
-
UO Ematologia Azienda Ospedaliero-Universitaria "Policlinico Rodolico San Marco"
ACTIVE_NOT_RECRUITINGCatania, Italy
-
UOC di Ematologia, Dipartimento di Oncologia, AOU Policlinico "Paolo Giaccone"
ACTIVE_NOT_RECRUITINGPalermo, Italy
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.